Cargando…

Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer

Angiotensin-converting enzyme 2 (ACE2) plays a pivotal role in the renin–angiotensin system and is closely related to coronavirus disease of 2019. However, the role of ACE2 in cancers remains unclear. We explored the pan-cancer expression patterns and prognostic value of ACE2 across multiple databas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Huan, Wei, Xian, Pang, Linhao, Wu, Yue, Hu, Bintao, Ruan, Yajun, Liu, Zhuo, Liu, Jihong, Wang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490340/ https://www.ncbi.nlm.nih.gov/pubmed/33088807 http://dx.doi.org/10.3389/fmolb.2020.00189

Ejemplares similares

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognostic and Immunological Role of PAFAH1B in Pan-Cancer
por: Yuan, Yixiao, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Inhibitor Protects Against Cisplatin Nephrotoxicity by Modulating Kinin B1 Receptor Expression and Aminopeptidase P Activity in Mice
por: Estrela, Gabriel R., et al.
Publicado: (2020)

Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of VSTM2L in Cancer
por: Zhang, Shuyi, et al.
Publicado: (2022)

Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer
por: Wang, Yanghao, et al.
Publicado: (2023)

Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity
por: Chen, Fei, et al.
Publicado: (2022)

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
por: Soltan, Mohamed A., et al.
Publicado: (2023)

The Predictive Competing Endogenous RNA Regulatory Networks and Potential Prognostic and Immunological Roles of Cyclin A2 in Pan-Cancer Analysis
por: Chen, Shenyong, et al.
Publicado: (2022)

Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies
por: Sun, Aijun, et al.
Publicado: (2023)

Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types
por: Yang, Changsheng, et al.
Publicado: (2020)

Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
por: Tan, Haotian, et al.
Publicado: (2021)

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)

Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis
por: Bahramy, Afshin, et al.
Publicado: (2023)

Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis
por: Liu, Yi, et al.
Publicado: (2021)

LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers
por: Xiao, Junbo, et al.
Publicado: (2021)

A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy
por: Zhou, Zheng, et al.
Publicado: (2022)

MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
por: Liu, Yi, et al.
Publicado: (2021)

Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer
por: Zhao, Lianfang, et al.
Publicado: (2023)

CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis
por: Guo, Lihao, et al.
Publicado: (2021)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort
por: Jia, Chenguang, et al.
Publicado: (2022)

A Pan-Cancer Analysis of IRAK1 Expression and Their Association With Immunotherapy Response
por: Liu, Mengmeng, et al.
Publicado: (2022)

RelB is a potential molecular biomarker for immunotherapy in human pan-cancer
por: Wu, Jintao, et al.
Publicado: (2023)

An Integrative Pan-Cancer Analysis of PBK in Human Tumors
por: Wen, Huantao, et al.
Publicado: (2021)

Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers
por: Li, Rui, et al.
Publicado: (2021)

Circadian Clock Genes Modulate Immune, Cell Cycle and Apoptosis in the Diagnosis and Prognosis of Pan-Renal Cell Carcinoma
por: Liu, Shuwen, et al.
Publicado: (2021)

Pan-Cancer Transcriptome and Immune Infiltration Analyses Reveal the Oncogenic Role of Far Upstream Element-Binding Protein 1 (FUBP1)
por: Wang, Huan, et al.
Publicado: (2022)

A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of Heat Shock Protein 110, 90, 70, and 60 Families
por: Yan, Li-rong, et al.
Publicado: (2021)

Pan-Cancer Analysis of the Associations of TGFBI Expression With Prognosis and Immune Characteristics
por: Chen, Yun, et al.
Publicado: (2021)

Elucidating the Activation Mechanism of AMPK by Direct Pan-Activator PF-739
por: Aledavood, Elnaz, et al.
Publicado: (2021)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

The oncogenic role of SNRPB in human tumors: A pan-cancer analysis
por: Wu, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hma02ci14capb0uv0c0niklj7n